Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02000167 · ClinicalTrials.gov registry record
Mitochondrial Dysfunction in Phelan-McDermid Syndrome
A clinical trial of Phelan-McDermid Syndrome, sponsored by University of Arkansas.
- Completed
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT02000167: Completed study of Phelan-McDermid Syndrome, sponsored by University of Arkansas.
NCT02000167 is a study of Phelan-McDermid Syndrome that has completed, run by University of Arkansas. The registered enrollment target is 51 participants, below the 99-participant average among 4 other Phelan-McDermid Syndrome trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02000167, a study of Phelan-McDermid Syndrome, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a relationship exists between gene deletion(s) specific to the mitochondrial electron transport chain and presentation of clinical characteristics in patients with Phelan-McDermid Syndrome (PMS).
Primary Outcome
Electron transport chain (ETC) function will be measured in cells collected using Buccal swabs to determine if certain PMS patients symptomatology and clinical characteristics/variations can be explained due to variations in patterns of ETC function in this cohort
Conditions Studied
Study Locations (1)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-05 |
What the finished NCT02000167 record still lists
NCT02000167 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 99-participant average among 4 other Phelan-McDermid Syndrome trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Phelan-McDermid Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02000167 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT02000167 about?
NCT02000167 is a clinical study titled "Mitochondrial Dysfunction in Phelan-McDermid Syndrome". The purpose of this study is to determine whether a relationship exists between gene deletion(s) specific to the mitochondrial electron transport chain and presentation of clinical characteristics in patients with Phelan-McDermid Syndrome (PMS).
What is the current status of trial NCT02000167?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2012-05. Estimated completion is 2015-05.
What conditions does trial NCT02000167 study?
This clinical trial studies the following conditions: Phelan-McDermid Syndrome.
Who is sponsoring clinical trial NCT02000167?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02000167 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phelan-McDermid Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency
RECRUITING · Phase 1
-
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
RECRUITING · Phase 3
-
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
ACTIVE NOT RECRUITING
-
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia